GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cantel Medical Corp (NYSE:CMD) » Definitions » Gross Profit

Cantel Medical (Cantel Medical) Gross Profit : $539 Mil (TTM As of Apr. 2021)


View and export this data going back to 1992. Start your Free Trial

What is Cantel Medical Gross Profit?

Cantel Medical's gross profit for the three months ended in Apr. 2021 was $151 Mil. Cantel Medical's gross profit for the trailing twelve months (TTM) ended in Apr. 2021 was $539 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Cantel Medical's gross profit for the three months ended in Apr. 2021 was $151 Mil. Cantel Medical's Revenue for the three months ended in Apr. 2021 was $314 Mil. Therefore, Cantel Medical's Gross Margin % for the quarter that ended in Apr. 2021 was 48.20%.

Cantel Medical had a gross margin of 48.20% for the quarter that ended in Apr. 2021 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Cantel Medical was 47.67%. The lowest was 38.17%. And the median was 44.25%.


Cantel Medical Gross Profit Historical Data

The historical data trend for Cantel Medical's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantel Medical Gross Profit Chart

Cantel Medical Annual Data
Trend Jul11 Jul12 Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 309.19 367.16 413.97 427.45 435.97

Cantel Medical Quarterly Data
Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 100.98 96.88 147.37 143.48 151.32

Competitive Comparison of Cantel Medical's Gross Profit

For the Medical Instruments & Supplies subindustry, Cantel Medical's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantel Medical's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cantel Medical's Gross Profit distribution charts can be found below:

* The bar in red indicates where Cantel Medical's Gross Profit falls into.



Cantel Medical Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Cantel Medical's Gross Profit for the fiscal year that ended in Jul. 2020 is calculated as

Gross Profit (A: Jul. 2020 )=Revenue - Cost of Goods Sold
=1016.048 - 580.075
=436

Cantel Medical's Gross Profit for the quarter that ended in Apr. 2021 is calculated as

Gross Profit (Q: Apr. 2021 )=Revenue - Cost of Goods Sold
=313.953 - 162.63
=151

Gross Profit for the trailing twelve months (TTM) ended in Apr. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $539 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Cantel Medical's Gross Margin % for the quarter that ended in Apr. 2021 is calculated as

Gross Margin % (Q: Apr. 2021 )=Gross Profit (Q: Apr. 2021 ) / Revenue (Q: Apr. 2021 )
=(Revenue - Cost of Goods Sold) / Revenue
=151 / 313.953
=48.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Cantel Medical  (NYSE:CMD) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Cantel Medical had a gross margin of 48.20% for the quarter that ended in Apr. 2021 => Durable competitive advantage


Cantel Medical Gross Profit Related Terms

Thank you for viewing the detailed overview of Cantel Medical's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantel Medical (Cantel Medical) Business Description

Traded in Other Exchanges
N/A
Address
150 Clove Road, 9th Floor, Little Falls, NJ, USA, 07424
Cantel Medical is a New Jersey-based manufacturer of hospital supplies for infection prevention, which include products used in endoscope disinfection, water purification systems for use in dialysis treatment, and dental supplies. The firm reports in four segments: medical (46% of fiscal 2020 sales), dental (32%), life sciences (19%), and dialysis (3%). Geographic exposure is primarily in the U.S., which accounts for about 75% of revenue, with international markets making up the remaining 25%.
Executives
Ann E Berman director 255 STATE STREET, BOSTON MA 02109
Jeffrey Z Mann officer: SVP, General Counsel 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
George L Fotiades director, officer: Chief Executive Officer 281 SUMMIT AVENUE, SUMMIT NJ 07901
Charles M Diker director, 10 percent owner, officer: Chairman ONE NEW YORK PLAZA, NEW YORK NY 10004
Shaun M. Blakeman officer: SVP - CFO C/O CANTEL MEDICAL CORP., 150 CLOVE ROAD, LITTLE FALLS NJ 07424
Jean Casner officer: SVP and CHRO 150 CLOVE ROAD, LITTLE FALLS NJ 07424
Brian Capone officer: SVP and Princ. Accounting Ofr 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Peter G Clifford officer: President and COO 40 TOURNAMENT DRIVE SOUTH, HAWTHORN WOODS IL 60047
Seth M Yellin officer: Executive Vice President 150 CLOVE ROAD 9TH FLOOR LITTLE FALLS NJ 07424
Laura L Forese director 849 STONEWALL COURT FRANKLIN LAKES NJ 07417
Peter Pronovost director JHU-QSRG 1909 THAMES ST. - 2ND FLOOR BALTIMORE MD 21231
Anthony B Evnin director C/O VENROCK ASSOCIATES, 7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018
Ronnie Myers director TOURO COLLEGE OF DENTAL MEDICINE 40 SUNSHINE COTTAGE ROAD VALHALLA NY 10595
Alan R Batkin director 399 PARK AVENUE, 10TH FLOOR, NEW YORK NY 10022
Karen Prange director 1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316

Cantel Medical (Cantel Medical) Headlines